Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans

Circulation

Volumn 89, Issue 5, 1994, Pages 2035-2040

  Stamler, Jonathan S ^a   Loh, Evan ^a   Roddy, Mary Anne ^a   Currie, Kristen E ^a   Creager, Mark A ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

blood pressure; endothelium; N(G) monomethyl L arginine; relaxing factors

Indexed keywords

NITRIC OXIDE;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; FEMALE; HEART HEMODYNAMICS; HEART STROKE VOLUME; HUMAN; HUMAN EXPERIMENT; LUNG ARTERY PRESSURE; LUNG CAPILLARY PRESSURE; LUNG HEMODYNAMICS; LUNG VASCULAR RESISTANCE; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SYSTEMIC VASCULAR RESISTANCE;

EID: 0028314525     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.89.5.2035     Document Type: Article

References (49)

1. Palmer RMJ, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature. 1988;333:664-666.
2. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci U S A. 1987;84: 9265-9269.
3. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J. 1992;6:3051-3064.
4. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991;43: 109-142.
5. Stuehr DJ, Griffith DW. Mammalian nitric oxide syntheses. Adv Enzymol Relat Areas Mol Biol. 1992;65:287-343.
6. G-Methylarginine, an inhibitor of endothelium-derived nitric oxide synthesis, is a potent pressor agent in the guinea pig: does nitric oxide regulate blood pressure in vivo? Biochem Biophys Res Commun. 1989;160:881-886.
7. Rees DD, Palmer RMJ, Moncada S. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci U S A. 1989;86:3375-3378.
8. Halbrügge T, Lütsch K, Thyen A, Graefe KH. Vasodilatation by endothelium-derived nitric oxide as a major determinant of noradrenaline release. J Neural Transm. 1991;34:113-119.
9. Tresham JJ, Dusting GJ, Coghlan JP, Whitmore JA. Haemodynamic and hormonal effects of N-nitro-L-arginine, an inhibitor of nitric oxide biosynthesis, in sheep. Clin Exp Pharmacol Physiol. 1991;18:327-330.
10. Loeb AL, Longnecker DE. Inhibition of endothelium-derived relaxing factor-dependent circulatory control in intact rats. Am J Physiol. 1992;262:H1494-H1500.
11. Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet. 1989;2: 997-1000.
12. Ignarro LJ, Byrns RE, Buga GM, Wood KS. Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical. Circ Res. 1987;61:866-879.
13. Cremona G, Dinh-Xuan AT, Higenbottam TW. Endothelium-derived relaxing factor and the pulmonary circulation. Lung. 1991; 169:185-202.
14. Dinh-Xuan AT. Endothelial modulation of pulmonary vascular tone. Eur Respir J. 1992;5:757-762.
15. Fineman JR, Chang R, Soifer SJ. EDRF inhibition augments pulmonary hypertension in intact newborn lambs. Am J Physiol. 1992;262:H1365-H1371.
16. Dinh-Xuan AT, Higenbottam TW, Clelland CA, Pepke-Zaba J, Cremona G, Butt AY, Large SR, Wells FC, Wallwork J. Impairment of endothelium-dependent pulmonary-artery relaxation in chronic obstructive lung disease. N Engl J Med. 1991;324:1539-1547.
17. Archer SL, Tolins JP, Raij L, Weir EK. Hypoxic pulmonary vasoconstriction is enhanced by inhibition of the synthesis of an endothelium derived relaxing factor. Biochem Biophys Res Commun. 1989;164:1198-1205.
18. ω-Nitro-L-arginine and pulmonary vascular pressure-flow relationship in conscious dogs. Am J Physiol. 1992; 262:H1331-H1337.
19. ω-Nitro-L-arginine methyl ester selectively inhibits pulmonary vasodilator responses to acetylcholine and bradykinin. J Appl Physiol. 1991;71: 2026-2031.
20. Perrella MA, Hildebrand FL, Margulies KB, Burnett JC. Endothelium-derived relaxing factor in regulation of basal cardiopulmonary and renal function. Am J Physiol. 1991;261:R323-R328.
21. Abman SH, Chatfield BA, Hall SL, McMurtry IF. Role of endothelium-derived relaxing factor during transition of pulmonary circulation at birth. Am J Physiol. 1990;259:H1921-H1927.
22. ω-Nitro-L-arginine attenuates endothelium-dependent pulmonary vasodilation in lambs. Am J Physiol. 1991;260:H1299-H1306.
23. Hasunuma K, Yamaguchi T, Rodman DM, O'Brien F, McMurtry IF. Effects of inhibitors of EDRF and EDHF on vasoreactivity of perfused rat lungs. Am J Physiol. 1991;260:L97-L104.
24. Persson MG, Gustafsson LE, Wiklund NP, Moncada S, Hedqvist P. Endogenous nitric oxide as a probable modulator of pulmonary circulation and hypoxic pressor response in vivo. Acta Physiol Scand. 1990;140:449-457.
25. Archer SL, Rist K, Nelson DP, Demaster EG, Cowan N, Weir EK. Comparison of the hemodynamic effects of nitric oxide and endothelium-dependent vasodilators in intact lungs. J Appl Physiol. 1990;68:735-747.
26. Brashers VL, Peach MJ, Rose CE. Augmentation of hypoxic pulmonary vasoconstriction in the isolated perfused rat lung by in vitro antagonists of endothelium-dependent relaxation. J Clin Invest. 1988;82:1495-1502.
27. Fineman JR, Crowley MR, Heymann MA, Soifer SJ. In vivo attenuation of endothelium-dependent pulmonary vasodilation by methylene blue. J Appl Physiol. 1991;71:735-741.
28. Cherry PD, Gillis CN. Evidence for the role of endothelium-derived relaxing factor in acetylcholine-induced vasodilatation in the intact lung. J Pharmacol Exp Ther. 1987;241:516-520.
29. Hyman AL, Kadowitz PJ, Lippton HL. Methylene blue selectively inhibits vasodilator responses in cats. J Appl Physiol. 1989;66: 1513-1517.
30. Liu S, Crawley DE, Barnes PJ, Evans TW. Endothelium-derived relaxing factor inhibits hypoxic pulmonary vasoconstriction in rats. Am Rev Respir Dis. 1991;143:32-37.
31. Mazmanian G, Baudet B, Brink C, Cerrina J, Kirkiacharian S, Weiss M. Methylene blue potentiates vascular reactivity in isolated rat lungs. J Appl Physiol. 1989;66:1040-1045.
32. Meredith IT, Hoffmann KE, Anderson TJ, Roddy MA, Ganz P, Creager MA. Post-ischemic vasodilation in the human forearm is dependent on endothelium-derived relaxing factor. Clin Res. 1993; 41:192A. Abstract.
33. Petros A, Bennet D, Vallance P. Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet. 1991;338:1557-1558.
34. Stamler JS, Jaraki O, Osborne J, Simon DI, Keaney J, Vita J, Singel D, Valeri B, Loscalzo J. Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. Proc Natl Acad Sci U S A. 1992;89:7674-7677.
35. G-Methyl-L-arginine causes endothelium-dependent contraction and inhibition of cyclic GMP formation in artery and vein. Proc Natl Acad Sci U S A. 1990;87:4430-4434.
36. Ignarro LJ, Byrns RE, Buga GM, Wood KS. Endothelium-dependent modulation of cGMP levels and intrinsic smooth muscle tone in isolated bovine intrapulmonary artery and vein. Circ Res. 1987;60:82-92.
37. G-Monomethyl-L-arginine causes nitric oxide synthesis in isolated arterial rings: trouble in paradise. Biochem Biophys Res Commun. 1992;188;590-596.
38. Klabunde RE, Ritger RC, Helgren MC. Cardiovascular actions of inhibitors of endothelium-derived relaxing factor (nitric oxide) formation/release in anesthetized dogs. Eur J Pharmacol. 1991;199: 51-59.
39. Lefroy DC, Crake T, Uren NG, Davies GJ, Maseri A. Effect of inhibition of nitric oxide synthesis in the human epicardial coronary artery caliber and coronary blood flow in humans. Circulation. 1993;88:43-54.
40. 1-adrenergic receptor stimulation and blockade on contractility in humans. Circulation. 1991;84:1608-1614.
41. Balligand JL, Kelly RA, Marsden PA, Smith TW, Michel T. Control of cardiac muscle cell function by an endogenous nitric oxide signaling system. Proc Natl Acad Sci U S A. 1993;90:347-351.
42. Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG, Simmons RL. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science. 1992;257:387-389.
43. Brady AJB, Warren JB, Poole-Wilson PA, Williams TJ, Harding SE. Nitric oxide attenuates cardiac myocyte contraction. Am J Physiol. 1993;265(Heart Circ Physiol 34):H176-H182.
44. DeBelder AJ, Radomski MW, Why HJF, Richardson PJ, Bucknall CA, Salas E, Martin JF, Moncada S. Nitric oxide synthase activities in human myocardium. Lancet. 1993;341:84-85.
45. Brady AJ, Poole-Wilson PA, Harding SE, Warren JB. Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia. Am J Physiol. 1992;263:H1963-H1966.
46. Gaston B, Reilly J, Drazen JM, Fackler T, Ramdev P, Arnelle DA, Mullins ME, Sugarbaker DJ, Chee C, Singel DJ, Loscalzo J, Stamler JS. Endogenous nitrogen oxides and bronchodilator S-nitrosothiols in human airways. Proc Natl Acad Sci U S A. 1993; 90:10957-10961.
47. Stamler JS, Singel D, Loscalzo J. Biochemistry of nitric oxide and its redox activated forms. Science. 1992;258:1898-1902.
48. G-monomethyl-L-arginine in patients with hypertension: the nitric oxide dilator mechanism appears abnormal. J Hypertens. 1992;10:1025-1031.
49. Klimaschewski L, Kummer W, Mayer B, Couraud JY, Preissler U, Philippin B, Heym C. Nitric oxide synthase in cardiac nerve fibers and neurons of rat and guinea pig heart. Circ Res. 1992;71: 1533-1537.